EDAP TMS SA (FOCL) stock: key figures, P/E, revenue and dividend
Health Care · France · ISIN US2683111072
EDAP TMS SA financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 70.53 m USD |
| Gross profit | 30.00 m USD |
| Operating income | -24.69 m USD |
| EBIT | -28.27 m USD |
| Net income | -29.25 m USD |
| Diluted EPS – continuing operations | -0.78 USD |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About EDAP TMS SA
EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. It also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. In addition, the company manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters; and sells spare parts and disposables, such as electrodes. Further, it markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales channels, and third-party distributors and agents. The company serves academic, public, and private hospitals, as well as clinics. The company has a strategic collaboration with Telix Pharmaceuticals Limited to develop clinical workflows combining PSMA PET imaging and Focal One Robotic HIFU for prostate cancer. EDAP TMS S.A. was incorporated in 1979 and is headquartered in Vaulx-en-Velin, France.
More stocks
- Gesco (GSC1.DE)
- Immuneering Corp (IMRX)
- Foraco International SA (FAR.TO)
- Eagle Bancorp Montana, Inc. (EBMT)
- Xponential Fitness, Inc. (XPOF)
- Hushan Autoparts Inc. (7736.TW)
- Guanajuato Silver Company Ltd (GSVR.V)
- Revival Gold Inc (RVG.V)
- Digimarc Corporation (DMRC)
- Nordic Halibut AS (NOHAL.OL)
- DUOS TECHNOLOGIES GROUP, INC. (DUOT)
- Duta Intidaya Tbk PT (DAYA.JK)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.